Gutachten des Sachverständigenrates Gesundheit & Pflege zum Thema Fachkräfte im Gesundheitswesen wurde gestern vorgestellt. Großer Dank an 6 Ratskolleginnen und -kollegen und Geschäftsstelle des SVR für die engagierte, kompetente Zusammenarbeit.

svr-gesundheit.de/fileadmin/Guta…

#Sepsis : mittlerweile die dritthäufigste Todesursache in Deutschland. Grundsätzlich jede Infektion kann sie auslösen und jeder kann sie bekommen. Dr. Schommers informiert dazu in der WDR-Sendung 'Hier und heute' (zu Beginn und ab 01:08h): ardmediathek.de/video/Y3JpZDov…

An excellent opportunity for young, motivated postdocs and students who wish to perform successful #research on the evolution and plasticity of B cell malignancies in #Cologne . Universität zu Köln Uniklinik Köln #lymphoma #leusm #CECAD #SFB1530

One more day to submit your application for the prestigious Goldman Research Award 2024 of ESH (Haematology)

Absolutely thrilled to have been part of the #GCLLSG workshop in Cologne and reconnect with all my CLL colleagues again! The lineup of speakers was not only impressive but also enlightening.Immensely grateful to Michael Hallek,Barbara Eichhorst, Othman Al-Sawaf &Kirsten Fischer

Congratulations ⁦Paul Hampel⁩ on receiving the best abstract award at the 2024 YIM GCLLSG meeting in Koln! A fantastic conference! #GCLLSG ⁦Mayo Clinic Comprehensive Cancer Center⁩ ⁦⁦⁦Michael Hallek⁩ ⁦Deborah Stephens⁩

Romain Guièze, Romain Guieze, from Clermont-Ferrand, France, explains how to manage #Richter transformation at the #GCLLSG workshop in #Cologne . Excellent summary. #CLL #leusm #GCLLSG 2024

Great two days at German CLL Study group DCLLSG2024 Koln Matthew Davids, MD, MMSc Sameer Parikh Michael Hallek Othman Al-Sawaf

Presentation on future promising cell therapy treatments and bi-specific antibodies at the XIVth #iwDCLLSG by Francesc Bosch @sehh_es

Thanks to the #GCLLSG for the XIV International Workshop #GCLLSG 2024 it has been a wonderful experience to share these days dedicated to the study of #CLL , Michael Hallek we hope to see you in a couple of years at the next one. @sehh_es

Thank you for attending the meeting and for your excellent lecture.

Dr Sameer A Parikh from Mayo Clinic Rochester on his concepts for a “dream study” to create progress for #CLL patients at the international #GCLLSG workshop. #GCLLSG 2024 #leusm #Cologne

Lydia Scarfo from #Milano , Italy, summarizing the management and prevention of #infections in patients with #CLL at the international workshop of the #GCLLSG .
#GCLLSG 2024 #leusm #Cologne

Marta Coscia from #Torino , Italy, giving an excellent overview and treatment algorithm of #autoimmune complications in #CLL at the #GCLLSG workshop. #GCLLSG 2024 #leusm

Let’s last day of #GCLLSG begin!

Presentation of the ReVenG trial, an international cooperative study on #venetoclax and #obinutuzumab retreatment by our friend ⁦Matthew Davids, MD, MMSc⁩ of ⁦Dana-Farber⁩ Boston, in cooperation with the #GCLLSG . #CLL #leukemia

The XIVth International Workshop of the Germán CLL Study Group has just started Michael Hallek @sehh_es

15th International Workshop of the #GCLLSG started yesterday with brillant talks by an outstanding panel of speakers. This morning young investigator meeting: The future of #CLL research is bright.

Bendamustine, followed by obinutuzumab and idelalisib in chronic lymphocytic leukemia (CLL2-BCG): Final analysis of a phase II trial. Cramer et al., Am Hematol 2024, online.
#CLL #leusm #GCLLSG #leukemia Uniklinik Köln Universität zu Köln
pubmed.ncbi.nlm.nih.gov/38578022/

I enjoyed the discussions and interactions with you.